MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.
about
MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@en
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@nl
type
label
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@en
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@nl
prefLabel
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@en
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@nl
P2093
P2860
P1433
P1476
MiR-221/222 promote chemoresis ...... EN/PI3K/AKT signaling pathway.
@en
P2093
Hossein Teimori
Mehdi Shamsara
Mohammad Hossein Sangtarash
Zeinab Amini-Farsani
P2860
P2888
P356
10.1007/S10616-017-0134-Z
P577
2017-09-08T00:00:00Z